Jingyang Gao1,2, Manna Zhang1, Cuiling Zhu1, Yi Zhang1, Qi Liu3, Xingchun Wang1, Liang Li1, Donglei Zhou4, Shen Qu5,6,7. 1. Department of Endocrinology & Metabolism, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 301 Middle Yanchang Road, Shanghai, 200072, China. 2. Nanjing Medical University, 101 Longmian Avenue, Nanjing, Jiangsu Province, 211166, China. 3. Department of Central Laboratory, Shanghai Tenth People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200072, China. 4. National Metabolic Management Center, Shanghai Tenth People's Hospital, 301 Middle Yanchang Road, Shanghai, 200072, China. 5. Department of Endocrinology & Metabolism, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 301 Middle Yanchang Road, Shanghai, 200072, China. qushencn@hotmail.com. 6. Nanjing Medical University, 101 Longmian Avenue, Nanjing, Jiangsu Province, 211166, China. qushencn@hotmail.com. 7. National Metabolic Management Center, Shanghai Tenth People's Hospital, 301 Middle Yanchang Road, Shanghai, 200072, China. qushencn@hotmail.com.
Abstract
OBJECTIVE: The study was designed to examine changes of body fat distribution after laparoscopic sleeve gastrectomy (LSG) in obese male patients and to confirm whether these changes are correlated with increased testosterone. METHODS: A total of 30 obese male patients with body mass index (BMI) 30-45 kg/m2 were enrolled in this study. Data on demographic characteristics, anthropometry, metabolic parameters, and body fat distribution were collected at baseline and 6 months after LSG. Body fat distribution was assessed by dual-energy X-ray absorptiometry (DXA). RESULTS: Six months after surgery, the BMI of participants (age 33.0 ± 9.5) decreased from 40.2 ± 5.2 to 30.8 ± 4.4 kg/m2, total testosterone increased from 2.4 ± 1.2 to 4.5 ± 1.8 ng/mL, and the percentage of testosterone deficiency in these patients decreased from 82.7 to 23.1%. Fat mass was significantly decreased in all regions, but the loss of fat mass in the android region was more than that in any other body region. After adjusting age and the BMI, the changes in android FM% and gynoid FM% were significantly correlated with an increase in total testosterone concentration (R2 = 0.187, R2 = 0.282, respectively). CONCLUSION: In obese male patients with BMI 30-45 kg/m2, an increase of total testosterone correlated to the changes in android FM% and gynoid FM% at the sixth month after LSG surgery.
OBJECTIVE: The study was designed to examine changes of body fat distribution after laparoscopic sleeve gastrectomy (LSG) in obese malepatients and to confirm whether these changes are correlated with increased testosterone. METHODS: A total of 30 obese malepatients with body mass index (BMI) 30-45 kg/m2 were enrolled in this study. Data on demographic characteristics, anthropometry, metabolic parameters, and body fat distribution were collected at baseline and 6 months after LSG. Body fat distribution was assessed by dual-energy X-ray absorptiometry (DXA). RESULTS: Six months after surgery, the BMI of participants (age 33.0 ± 9.5) decreased from 40.2 ± 5.2 to 30.8 ± 4.4 kg/m2, total testosterone increased from 2.4 ± 1.2 to 4.5 ± 1.8 ng/mL, and the percentage of testosterone deficiency in these patients decreased from 82.7 to 23.1%. Fat mass was significantly decreased in all regions, but the loss of fat mass in the android region was more than that in any other body region. After adjusting age and the BMI, the changes in android FM% and gynoid FM% were significantly correlated with an increase in total testosterone concentration (R2 = 0.187, R2 = 0.282, respectively). CONCLUSION: In obese malepatients with BMI 30-45 kg/m2, an increase of total testosterone correlated to the changes in android FM% and gynoid FM% at the sixth month after LSG surgery.
Authors: Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen Journal: Endocr Rev Date: 2012-03-20 Impact factor: 19.871
Authors: Abdelouahid Tajar; Gianni Forti; Terence W O'Neill; David M Lee; Alan J Silman; Joseph D Finn; György Bartfai; Steven Boonen; Felipe F Casanueva; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Fernand Labrie; Michael E J Lean; Neil Pendleton; Margus Punab; Dirk Vanderschueren; Ilpo T Huhtaniemi; Frederick C W Wu Journal: J Clin Endocrinol Metab Date: 2010-02-19 Impact factor: 5.958
Authors: L Frederiksen; K Højlund; D M Hougaard; T H Mosbech; R Larsen; A Flyvbjerg; J Frystyk; K Brixen; M Andersen Journal: Eur J Endocrinol Date: 2011-12-21 Impact factor: 6.664
Authors: J I Botella-Carretero; J A Balsa; J M Gómez-Martin; R Peromingo; L Huerta; M Carrasco; F Arrieta; I Zamarron; A Martin-Hidalgo; C Vazquez Journal: J Endocrinol Invest Date: 2012-06-25 Impact factor: 5.467
Authors: Caterina Mammi; Matilde Calanchini; Antonella Antelmi; Francesca Cinti; Giuseppe M C Rosano; Andrea Lenzi; Massimiliano Caprio; Andrea Fabbri Journal: Int J Endocrinol Date: 2011-12-22 Impact factor: 3.257
Authors: Jeffrey A Keelan; Eugen Mattes; HaiWei Tan; Andrew Dinan; John P Newnham; Andrew J O Whitehouse; Peter Jacoby; Martha Hickey Journal: PLoS One Date: 2012-08-20 Impact factor: 3.240
Authors: Yung Lee; Jerry T Dang; Noah Switzer; James Yu; Chunhong Tian; Daniel W Birch; Shahzeer Karmali Journal: Obes Surg Date: 2019-01 Impact factor: 4.129